Deribe Kebede, Beng Amuam Andrew, Cano Jorge, Njouendo Abdel Jelil, Fru-Cho Jerome, Awah Abong Raphael, Eyong Mathias Esum, Chounna Ndongmo Patrick W, Giorgi Emanuele, Pigott David M, Golding Nick, Pullan Rachel L, Noor Abdisalan M, Enquselassie Fikre, Murray Christopher J L, Brooker Simon J, Hay Simon I, Enyong Peter, Newport Melanie J, Wanji Samuel, Davey Gail
Wellcome Trust Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School, Brighton, United Kingdom.
School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
PLoS Negl Trop Dis. 2018 Jan 11;12(1):e0006126. doi: 10.1371/journal.pntd.0006126. eCollection 2018 Jan.
Podoconiosis is a non-filarial elephantiasis, which causes massive swelling of the lower legs. It was identified as a neglected tropical disease by WHO in 2011. Understanding of the geographical distribution of the disease is incomplete. As part of a global mapping of podoconiosis, this study was conducted in Cameroon to map the distribution of the disease. This mapping work will help to generate data on the geographical distribution of podoconiosis in Cameroon and contribute to the global atlas of podoconiosis.
We used a multi-stage sampling design with stratification of the country by environmental risk of podoconiosis. We sampled 76 villages from 40 health districts from the ten Regions of Cameroon. All individuals of 15-years old or older in the village were surveyed house-to-house and screened for lymphedema. A clinical algorithm was used to reliably diagnose podoconiosis, excluding filarial-associated lymphedema. Individuals with lymphoedema were tested for circulating Wuchereria bancrofti antigen and specific IgG4 using the Alere Filariasis Test Strips (FTS) test and the Standard Diagnostics (SD) BIOLINE lymphatic filariasis IgG4 test (Wb123) respectively, in addition to thick blood films. Presence of DNA specific to W. bancrofti was checked on night blood using a qPCR technique.
Overall, 10,178 individuals from 4,603 households participated in the study. In total, 83 individuals with lymphedema were identified. Of the 83 individuals with lymphedema, two were found to be FTS positive and all were negative using the Wb123 test. No microfilaria of W. bancrofti were found in the night blood of any individual with clinical lymphedema. None were found to be positive for W. bancrofti using qPCR. Of the two FTS positive cases, one was positive for Mansonella perstans DNA, while the other harbored Loa loa microfilaria. Overall, 52 people with podoconiosis were identified after applying the clinical algorithm. The overall prevalence of podoconiosis was found to be 0.5% (95% [confidence interval] CI; 0.4-0.7). At least one case of podoconiosis was found in every region of Cameroon except the two surveyed villages in Adamawa. Of the 40 health districts surveyed, 17 districts had no cases of podoconiosis; in 15 districts, mean prevalence was between 0.2% and 1.0%; and in the remaining eight, mean prevalence was between 1.2% and 2.7%.
Our investigation has demonstrated low prevalence but almost nationwide distribution of podoconiosis in Cameroon. Designing a podoconiosis control program is a vital next step. A health system response to the burden of podoconiosis is important, through case surveillance and morbidity management services.
地方性象皮肿是一种非丝虫性象皮病,可导致小腿严重肿胀。2011年,它被世界卫生组织认定为一种被忽视的热带病。目前对该疾病地理分布的了解尚不完整。作为地方性象皮肿全球测绘的一部分,本研究在喀麦隆开展,以绘制该疾病的分布图。这项测绘工作将有助于生成喀麦隆地方性象皮肿地理分布的数据,并为全球地方性象皮肿地图集做出贡献。
我们采用多阶段抽样设计,根据地方性象皮肿的环境风险对该国进行分层。我们从喀麦隆十个地区的40个卫生区抽取了76个村庄。对村庄内所有15岁及以上的个体进行逐户调查,并筛查淋巴水肿。使用临床算法可靠地诊断地方性象皮肿,排除与丝虫相关的淋巴水肿。除厚血膜外,对淋巴水肿患者分别使用Alere丝虫病检测试纸(FTS)检测循环中的班氏吴策线虫抗原和使用标准诊断(SD)BIOLINE淋巴丝虫病IgG4检测(Wb123)检测特异性IgG4。使用qPCR技术检测夜间血液中班氏吴策线虫的特异性DNA。
总体而言,来自4603户家庭的10178名个体参与了研究。总共确定了83名淋巴水肿患者。在这83名淋巴水肿患者中,发现2人FTS检测呈阳性,使用Wb123检测全部为阴性。在任何临床诊断为淋巴水肿的个体的夜间血液中均未发现班氏吴策线虫微丝蚴。使用qPCR检测,未发现任何人的班氏吴策线虫呈阳性。在2例FTS阳性病例中,1例曼氏持久线虫DNA呈阳性,另1例带有罗阿丝虫微丝蚴。应用临床算法后,共确定了52例地方性象皮肿患者。发现地方性象皮肿的总体患病率为0.5%(95%[置信区间]CI;0.4 - 0.7)。除阿达马瓦两个被调查村庄外,喀麦隆每个地区至少发现1例地方性象皮肿病例。在接受调查的40个卫生区中,17个区没有地方性象皮肿病例;在15个区中,平均患病率在0.2%至1.0%之间;在其余8个区中,平均患病率在1.2%至2.7%之间。
我们的调查表明,喀麦隆地方性象皮肿患病率较低,但几乎在全国范围内分布。设计地方性象皮肿控制计划是至关重要的下一步。通过病例监测和发病管理服务,卫生系统应对地方性象皮肿负担非常重要。